Visual dysfunction in Parkinson's disease
- PMID: 10785835
Visual dysfunction in Parkinson's disease
Abstract
Several abnormalities of visual function have been demonstrated in Parkinson's disease (PD) by both electrophysiologic and psychophysical testing. Prolonged visual evoked potential latencies and abnormal electroretinographic patterns, both of which respond to levodopa therapy, have been demonstrated in Parkinson's disease patients and in primates with experimental parkinsonism suggesting that retinal dopamine deficiency is an important factor in the pathogenesis of PD visual dysfunction. Abnormalities of color perception, especially in the blue-green axis, and of visual contrast sensitivity (VCS) have also been well documented in PD patients. Although VCS impairment is likely related to retinal dopaminergic dysfunction, the fact that this visual abnormality is orientation-specific raises the possibility of visual cortex involvement as well. Visual abnormalities in PD are usually clinically occult and not likely to be uncovered during a routine neurological examination or by ordinary high contrast visual acuity testing. The clinician must be aware, however, that several forms of disability ranging from gait freezing to visual hallucinations may be linked to an underlying impairment of visual function in Parkinson's disease.
Similar articles
-
Abnormal psychophysical visual perception in Parkinson's disease patients.Acta Neurol Belg. 2003 Jun;103(2):83-7. Acta Neurol Belg. 2003. PMID: 12892001 Review.
-
Poor visual discrimination and visual hallucinations in Parkinson's disease.Clin Neuropharmacol. 1998 Sep-Oct;21(5):289-95. Clin Neuropharmacol. 1998. PMID: 9789709 Clinical Trial.
-
Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.Brain. 2005 Oct;128(Pt 10):2260-71. doi: 10.1093/brain/awh581. Epub 2005 Jul 6. Brain. 2005. PMID: 16000338
-
Impairment of high-contrast visual acuity in Parkinson's disease.Mov Disord. 1992;7(3):232-8. doi: 10.1002/mds.870070308. Mov Disord. 1992. PMID: 1620141
-
Visual and visual cognitive dysfunction in Parkinson's disease: spatial and chromatic vision.Adv Neurol. 1999;80:383-8. Adv Neurol. 1999. PMID: 10410745 Review. No abstract available.
Cited by
-
Alzheimer's Retinopathy: Seeing Disease in the Eyes.Front Neurosci. 2020 Sep 8;14:921. doi: 10.3389/fnins.2020.00921. eCollection 2020. Front Neurosci. 2020. PMID: 33041751 Free PMC article. Review.
-
ON and OFF channels in human retinal ganglion cells.J Physiol. 2013 Jan 1;591(1):327-37. doi: 10.1113/jphysiol.2012.243683. Epub 2012 Oct 15. J Physiol. 2013. PMID: 23070704 Free PMC article.
-
Visual symptoms in Parkinson's disease.Parkinsons Dis. 2011;2011:908306. doi: 10.4061/2011/908306. Epub 2011 May 25. Parkinsons Dis. 2011. PMID: 21687773 Free PMC article.
-
Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson's disease.Eur J Med Res. 2014 May 24;19(1):29. doi: 10.1186/2047-783X-19-29. Eur J Med Res. 2014. PMID: 24886673 Free PMC article.
-
Potential role of retina as a biomarker for progression of Parkinson's disease.Int J Ophthalmol. 2011;4(4):433-8. doi: 10.3980/j.issn.2222-3959.2011.04.21. Epub 2011 Aug 18. Int J Ophthalmol. 2011. PMID: 22553695 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical